Investment Highlights:

~ Althea has completed its first shipment of medicinal cannabis products to Germany

~ Initial shipment of 2,000 units valued at approximately $1,000,000 (EUR640,000)

~Althea has partnered with one of the country’s leading pharmaceutical wholesalers of cannabis-based medicines, Nimbus Health GmbH, to launch the brand exclusively in Germany

~ Under Althea and Nimbus’ agreement, Althea will receive payment for products supplied to Nimbus, along with 50% of net profit

~The German medicinal cannabis market is the largest medicinal cannabis market in Europe and health insurers typically cover the entire cost of medicinal cannabis treatments

December sales exceed $1.19M with 90% monthly growth in UK

Investment Highlights:

• Althea achieved record sales of $1,190,473 in December 2020, an increase of 40% from November 2020, and the first time monthly sales have exceeded $1 million

• Australian sales were a record $902,466 for December 2020, an increase of 22% month-on month

• UK sales were a record $209,706 in December 2020, an increase of 90% from November 2020, and further evidence of Althea’s first-mover advantage in the territory